Latest filing published 09 Apr 2026 for Adial Pharmaceuticals, INC..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Robertson H. Gilliland on record concern Adial Pharmaceuticals, Inc. In total, 3 filings cover trades dated from 31 July 2018 to 7 April 2026.
Every open-market trade on record is a purchase: 1 purchase, and no sale. The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant.
The latest filing, published on 9 April 2026, reports a share grant in Adial Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 3,005 days ago, on 2 August 2018. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations